Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
18.64
-0.55 (-2.87%)
At close: Sep 11, 2026, 4:00 PM EDT
18.85
+0.21 (1.13%)
After-hours: Sep 11, 2026, 7:38 PM EDT
Legend Biotech Market Cap
Legend Biotech has a market cap or net worth of $3.61 billion as of September 11, 2026. Its market cap has decreased by -41.53% in one year.
Market Cap
3.61B
Enterprise Value
2.93B
1-Year Change
-41.53%
Ranking
Category
Stock Price
$18.64
ChartMarket Cap Chart
Since June 5, 2020, Legend Biotech's market cap has decreased from $4.79B to $3.61B, a decrease of -24.53%. That is a compound annual growth rate of -4.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 3.61B | -10.04% |
| Dec 31, 2025 | 4.02B | -32.74% |
| Dec 31, 2024 | 5.97B | -45.43% |
| Dec 29, 2023 | 10.94B | 30.89% |
| Dec 30, 2022 | 8.36B | 16.46% |
| Dec 31, 2021 | 7.18B | 92.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Celcuity | 4.08B |
| Tango Therapeutics | 4.01B |
| Enliven Therapeutics | 3.98B |
| Iovance Biotherapeutics | 3.90B |
| Telix Pharmaceuticals | 3.82B |
| Viking Therapeutics | 3.73B |
| IDEAYA Biosciences | 3.63B |
| AbCellera Biologics | 3.53B |